UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034061
Receipt number R000038825
Scientific Title A study for the effect of microorganism containing foods on skin condition. A randomized, double-blind, placebo-controlled, Parallel-group comparison trial.
Date of disclosure of the study information 2018/09/25
Last modified on 2019/10/25 13:14:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for the effect of microorganism containing foods on skin condition. A randomized, double-blind, placebo-controlled, Parallel-group comparison trial.

Acronym

A study for the effect of microorganism containing foods on skin condition

Scientific Title

A study for the effect of microorganism containing foods on skin condition. A randomized, double-blind, placebo-controlled, Parallel-group comparison trial.

Scientific Title:Acronym

A study for the effect of microorganism containing foods on skin condition

Region

Japan


Condition

Condition

None (Healthy adults)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of microorganism containing foods on skin conditions

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

- Analysis of skin microbiome
- Analysis of expression level of skin-condition-related genes

Key secondary outcomes

- Evaluation of skin condition by medical doctor
- Skin color difference (LAB value)
- Trans-epidermal water loss
- Skin moisture content
- VISIA skin analysis
- Questionnaires


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Microorganism containing food (capsule form), once a day for 8 weeks

Interventions/Control_2

Microorganism not containing food (capsule form), once a day for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Female

Key inclusion criteria

1)Healthy Japanese females aged from 20 to less than 45 years old, when giving the informed consent.
2)Healthy individuals not having any chronic disease.
3)Individuals whose skin bacteria can be detected from forehead.
4)Individuals who generally have skin problems.
5)Individuals who are working more than 3 days per week.
6)Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will.
7)Individuals who can accomplish their tasks in the study at the appointed date.
8)Individuals who are judged suitable for this study by the investigators.

Key exclusion criteria

1)Individuals who have diseases with medications.
2)Individuals who receive medications within 1 month before examination.
3)Individuals who have a medical history of serious disease of liver, kidney, heart, lung, blood and digestive tract.
4)Individuals who have severe skin disorder, such as skin burn.
5)Individuals who are difficult to take samples for gene expression analysis.
6)Individuals who refuse to disclose their biological sexes.
7)Individuals who may have an allergic symptom to test foods, or individuals who may have a serious allergic symptom to other foods, or medicaments.
8)Individuals who are alcoholic or have mental disorders.
9)Individuals who have a smoking habitat.
10)Individuals who will change their life style during test period, such as traveling for a long period.
11)Individuals who cannot keep from direct sunlight exposure, such as tanning activities, during test period.
12)Individuals who may occur seasonal allergic symptoms, such as hay fever, and receive medications during test period.
13)Individuals who have severe menopausal symptoms.
14)Individuals who are taking or took foods or medications, specified for skin conditions or are planning to take these foods during test period.
15)Individuals who cannot stop eating foods related with this test foods during test period.
16)Individuals who have severe anemia.
17)Individuals who donate more than 200 ml of blood within 1 month or more than 400 ml of blood within 3 months.
18)Individuals who have a surgical or treatment history on the regions of measurement within 6 months.
19)Individuals who are pregnant, breastfeeding, or planning to be pregnant in the near future.
20)Individuals who are participating or participated in another clinical trial within the last 3 months.
21)Individuals who and whose family living with them work for a company manufacturing or selling healthy foods or cosmetics.
22)Individuals who are judged as unsuitable for participating this study by the investigator.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Takahiro
Middle name
Last name Ono

Organization

Ueno Asagao Clinic

Division name

Director

Zip code

110-0015

Address

Kairaku Building 6th floor, 2-7-5, Higashiueno, Taito-ku, Tokyo, Japan

TEL

03-6240-1162

Email

info@ueno-asagao.clinic


Public contact

Name of contact person

1st name Toshiyasu
Middle name
Last name amura

Organization

TES holdings Co., Ltd.

Division name

Division of Clinical Research Business

Zip code

110-0015

Address

Kairaku Building 6th floor, 2-7-5, Higashiueno, Taito-ku, Tokyo, Japan

TEL

03-6801-8480

Homepage URL


Email

t.tamura@tes-h.co.jp


Sponsor or person

Institute

TES holdings Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kirin Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of the Oriental Ueno Detection Center

Address

1-20-11, Ueno, Taito-ku, Tokyo, Japan

Tel

03-5816-0711

Email

info@tes-h.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

うえのあさがおクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

70

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 20 Day

Date of IRB

2018 Year 08 Month 20 Day

Anticipated trial start date

2018 Year 09 Month 26 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 07 Day

Last modified on

2019 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038825


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name